Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TSC2 |
Variant | R905Q |
Impact List | missense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | TSC2 R905Q does not lie within any known functional domains of the Tsc2 protein (UniProt.org). R905Q results in chaperone function, Tsc2 phosphorylation, Tsc1 binding, and Tsc1 subcellular localization similar to wild-type Tsc2 (PMID: 11741832) but results in decreased suppression of S6k phosphorylation (PMID: 15483652, PMID: 21309039), failure to activate Rheb GTPase activity (PMID: 15483652), and decreased Tsc2 stability in culture (PMID: 16464865, PMID: 21309039), and therefore, is predicted to lead to a loss of Tsc2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
TSC2 mutant TSC2 inact mut TSC2 R905Q |
Transcript | NM_000548.5 |
gDNA | chr16:g.2076142G>A |
cDNA | c.2714G>A |
Protein | p.R905Q |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011522639.2 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
XM_011522637.2 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
XM_024450413.1 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
XM_011522637.3 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
NM_001406664.1 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
NM_001363528.2 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
NM_021055.3 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
XM_011522640.2 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
NM_000548.4 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
XM_005255529.4 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
NM_000548.5 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
NM_001370404.1 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
XM_011522636.2 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
XM_011522636.3 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
XM_011522639.3 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
NM_001406665.1 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
NM_001370405.1 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
NM_001077183.2 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
NM_001077183.3 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
XM_017023615.1 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
NM_001406663.1 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
XM_005255531.4 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
NM_001114382.2 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
NM_001114382.3 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
XM_017023616.1 | chr16:g.2076142G>A | c.2714G>A | p.R905Q | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|